Pacific Diabetes Technologies Inc

๐Ÿ“ Portland, United States๐Ÿ—“ Founded 2013๐Ÿ‘ฅ 17 employees๐Ÿ’ฐ Last funded Feb 2023
Pacific Diabetes Technologies (PDT) has developed a hollow glucose sensor that allows insulin infusion and continuous glucose monitoring (CGM) at a single site using only a single needle per week. The device reduces the pain and daily disruption of managing insulin-treated diabetes and improves user experience for Automated Insulin Delivery systems. PDTโ€™s products include a needle-free CGM Injection Port for insulin pens, a CGM Infusion Set for insulin pumps, and a CGM Infusion Cannula for use in tubeless patch pumps worn directly on the body. These time-saving devices reduce needle trauma, reduce adhesive irritation, and improve adherence among pediatric and reluctant adult patients.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2013
Founded
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Pacific Diabetes Technologies Inc?
Pacific Diabetes Technologies Inc has 1 investors on record on gritt.io and 1 late-stage investors.
When did Pacific Diabetes Technologies Inc last raise funding?
The most recent investment in Pacific Diabetes Technologies Inc recorded on gritt.io was in February 2023.
When was Pacific Diabetes Technologies Inc founded?
Pacific Diabetes Technologies Inc was founded in 2013.
What industry is Pacific Diabetes Technologies Inc in?
Pacific Diabetes Technologies Inc operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Pacific Diabetes Technologies Inc based?
Pacific Diabetes Technologies Inc is headquartered in Portland, United States.